The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA ...
The FSPA’s potential passage raises important questions about how it would interact with existing state-level anti-SLAPP laws ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback